AMBOSS's own three-phase integration roadmap, covered in detail elsewhere in this content series, offers a useful concrete framework for a much larger question every clinical AI platform moving towards EHR integration will eventually have to answer directly: at what point does a tool that helps a clinician become a tool that effectively acts for one, and where, precisely, should that line sit.
Five escalating levels of authority
It is worth laying out the full progression explicitly, since each step represents a genuinely different order of capability and risk. Retrieve information, the most basic level, simply surfaces relevant knowledge in response to a question. Summarise patient context adds a layer of interpretation, condensing a specific patient's record into a usable picture. Suggest an action goes further still, moving from describing the situation to recommending what should be done about it. Draft an order or note moves from recommendation into a concrete, specific artefact ready for use. And execute the action, the final and most consequential level, actually carries out or finalises that artefact without further human intervention.
Why each transition changes the underlying risk
Information retrieval, the first level, leaves interpretation principally with the clinician, who remains the one connecting the retrieved information to the actual patient and decision in front of them. Patient-specific recommendations, once the system moves beyond generic information towards a tailored suggestion, create considerably stronger automation bias, the well-documented tendency to trust a confident, personalised-looking recommendation more than it necessarily deserves. Write-back, sending a draft directly into the formal record, can turn a single error into a persistent artefact within that record, potentially propagating forward into every future encounter that draws on it. And execution, the final level, may directly affect patient care without any further human check standing between the system's output and its real-world consequence.
Appropriate safeguards at every level
Regardless of which specific level a given system operates at, several safeguards deserve to be treated as close to non-negotiable. No autonomous execution of anything with genuine clinical consequence, without an explicit, meaningful human decision point. Clear statement of the assumptions any recommendation rests on, rather than presenting a conclusion without its reasoning visible. Source links attached to every substantive claim. Explicit expression of confidence and uncertainty, rather than uniform, undifferentiated confidence regardless of how well-supported a given answer actually is. Mandatory clinician confirmation before anything becomes part of the formal record. A complete audit log, allowing any output to be traced back to exactly what informed it. And easy reversal, ensuring a mistaken action or entry can be corrected quickly rather than becoming difficult to undo once made.
Should orders, notes and recommendations carry different approval standards?
It is worth asking this directly rather than assuming a single uniform standard fits every kind of output. A draft note describing an encounter carries different, generally lower immediate risk than a draft medication order, which itself may carry different risk again depending on the specific medicine and dose involved. A genuinely mature system would plausibly apply a correspondingly graduated approval standard, rather than treating every kind of AI-generated suggestion identically regardless of its actual potential consequence.
The specific problem of copied-forward AI content
A particular, sharpened version of an existing clinical documentation problem deserves direct naming: clinical records have long suffered from copied-forward inaccuracies, where an error entered once persists silently across many subsequent entries. An AI system contributing content directly into that same record risks introducing this problem at a new scale and speed, and any system moving towards write-back capability needs a specific, deliberate design response to this risk, not simply an assumption that ordinary clinical review will reliably catch it.
Contrasting with iatroX's more bounded current role
iatroX's current role is deliberately narrower than the escalating framework described above: retrieving and explaining UK guidance in response to a clinician's question, while leaving chart interpretation and any resulting action explicitly with the clinician throughout. This is a conscious scope decision, not an unstated limitation, and this article makes no claim that iatroX currently operates at any of the higher levels described here.
A conclusion worth holding onto
Greater integration and greater apparent sophistication should be judged specifically by genuine clinical benefit relative to genuine clinical risk, not simply by how technically impressive the underlying capability is. A system that reads the chart, recommends an action and drafts the paperwork is not automatically better than one that stops at retrieving good information; it depends entirely on whether the additional capability is matched by equally serious governance at every step along the way.